Albert Liclican
Impact in
Papers in
-
- Synthesis and biological activity 4
-
- Melanoma and MAPK Pathways 3
- Protein Kinase Regulation and GTPase Signaling 3
- Co-authors
- Brian E. Schultz (4 shared papers)Melanie Wong (2 shared papers)Giuseppe A. Papalia (2 shared papers)Armando G. Villaseñor (2 shared papers)Ruth Wang (2 shared papers)Weimei Xing (3 shared papers)Roman Sakowicz (3 shared papers)Katherine M. Brendza (2 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (8 papers)Journal of Biological Chemistry (2 papers)SLAS DISCOVERY (1 paper)Blood (1 paper)Journal of Medicinal Chemistry (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Albert Liclican
14 papers receiving 463 citations
Peers
Comparison fields: 5 of 69
- Virology 63
- Genetics 112
- Infectious Diseases 95
- Hematology 54
- Organic Chemistry 136
Countries citing papers authored by Albert Liclican
This map shows the geographic impact of Albert Liclican's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Liclican with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Liclican more than expected).
Fields of papers citing papers by Albert Liclican
This network shows the impact of papers produced by Albert Liclican. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Liclican. The network helps show where Albert Liclican may publish in the future.
Co-authors
The 25 scholars most cited alongside Albert Liclican, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 119 | |
| 2 | 2009 | 86 | |
| 3 | 2017 | 76 | |
| 4 | 2020 | 74 | |
| 5 | 2007 | 36 | |
| 6 | 2009 | 21 | |
| 7 | 2008 | 14 | |
| 8 | 2008 | 13 | |
| 9 | 2018 | 13 | |
| 10 | 2010 | 12 | |
| 11 | 2008 | 9 | |
| 12 | 2008 | 6 | |
| 13 | 2010 | 2 | |
| 14 | 2016 | 2 |
About Albert Liclican
Albert Liclican is a scholar working on Organic Chemistry, Molecular Biology, Genetics, Oncology and Toxicology, having authored 14 papers that have together received 483 indexed citations. Recurring topics across this work include Synthesis and biological activity (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Melanoma and MAPK Pathways (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Bioactive Compounds and Antitumor Agents (3 papers), Lymphoma Diagnosis and Treatment (2 papers), HIV Research and Treatment (2 papers) and Computational Drug Discovery Methods (2 papers). The work is most often cited by research in Virology (63 citations), Genetics (112 citations), Infectious Diseases (95 citations), Hematology (54 citations) and Organic Chemistry (136 citations). Albert Liclican has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Brian E. Schultz, Melanie Wong, Giuseppe A. Papalia, Armando G. Villaseñor, Ruth Wang, Weimei Xing, Roman Sakowicz, Katherine M. Brendza, Mary E. McGrath and Leanna Lagpacan. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Biological Chemistry, SLAS DISCOVERY, Blood and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.